Contemporary clinical trials | 2021

The Nourish Protocol: A digital health randomized controlled trial to promote the DASH eating pattern among adults with hypertension.

 
 
 
 
 
 
 
 
 
 
 
 
 
 

Abstract


INTRODUCTION\nOver 100 million adults in the United States have hypertension. The DASH (Dietary Approaches to Stop Hypertension) eating pattern is an evidence-based first-line treatment option for hypertension; however, adherence to the DASH eating pattern at a population level remains low. To address this gap, we will implement Nourish, a randomized controlled efficacy trial that will leverage a commercially-available smartphone application and evidence-based behavior change principles to improve adherence to the DASH eating pattern among adults with hypertension.\n\n\nMETHODS\nThe Nourish trial is a two-arm, 12-month randomized control trial that will enroll adults (N\u202f=\u202f300) with hypertension, defined as a systolic blood pressure of 120-159\u202fmmHg; a diastolic blood pressure of 80-99\u202fmmHg; and/or adults on blood pressure-lowering medication. Nourish will test the efficacy of a digital health intervention, as compared to the attention control arm, on DASH eating pattern adherence and blood pressure. Intervention components will include skills training, self-monitoring, personalized feedback, and responsive coaching. The primary outcome of the trial is 6-month changes in adherence to the DASH eating pattern, as measured by 24-h dietary recalls.\n\n\nDISCUSSION\nMillions of Americans remain in need of effective behavioral interventions to manage and improve their hypertension and its adverse consequences. The ubiquity of smartphones offers a promising approach to disseminate the DASH eating pattern. By leveraging these widely used smartphone applications, combined with evidence-based behavior change principles and the DASH eating plan, Nourish will demonstrate the effectiveness of a digital health intervention to improve DASH adherence, and ultimately, to reduce blood pressure. Trial Number: NCT03875.

Volume None
Pages \n 106539\n
DOI 10.1016/j.cct.2021.106539
Language English
Journal Contemporary clinical trials

Full Text